These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23409060)

  • 41. The Use of PET Imaging for Prognostic Integrin α
    Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
    Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Facile synthesis and
    Walker D; Li Y; Roxin Á; Schaffer P; Adam MJ; Perrin DM
    Bioorg Med Chem Lett; 2016 Oct; 26(20):5126-5131. PubMed ID: 27623550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of Immuno-PET of CD138 and PET imaging with
    Bailly C; Gouard S; Lacombe M; Remaud-Le Saëc P; Chalopin B; Bourgeois M; Chouin N; Tripier R; Halime Z; Haddad F; Faivre-Chauvet A; Kraeber-Bodéré F; Chérel M; Bodet-Milin C
    Oncotarget; 2018 Feb; 9(10):9061-9072. PubMed ID: 29507674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monitoring CD8a
    Kristensen LK; Christensen C; Alfsen MZ; Cold S; Nielsen CH; Kjaer A
    Mol Imaging Biol; 2020 Aug; 22(4):1021-1030. PubMed ID: 32086762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement.
    Lapa C; Knop S; Schreder M; Rudelius M; Knott M; Jörg G; Samnick S; Herrmann K; Buck AK; Einsele H; Lückerath K
    Theranostics; 2016; 6(2):254-61. PubMed ID: 26877783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
    Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
    Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma.
    Haznedar R; Akı SZ; Akdemir OU; Ozkurt ZN; Ceneli O; Yağcı M; Sucak GT; Unlü M
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1046-53. PubMed ID: 21287167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting CAIX with [
    Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
    Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New synthesis of phenyl-isothiocyanate C-functionalised cyclams. Bioconjugation and (64)Cu phenotypic PET imaging studies of multiple myeloma with the te2a derivative.
    Halime Z; Frindel M; Camus N; Orain PY; Lacombe M; Bernardeau K; Chérel M; Gestin JF; Faivre-Chauvet A; Tripier R
    Org Biomol Chem; 2015 Dec; 13(46):11302-14. PubMed ID: 26419637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeted imaging of very late antigen-4 for noninvasive assessment of lung inflammation-fibrosis axis.
    Zhu Q; Barnes CE; Mannes PZ; Latoche JD; Day KE; Nedrow JR; Novelli EM; Anderson CJ; Tavakoli S
    EJNMMI Res; 2023 Jun; 13(1):55. PubMed ID: 37273103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial Experience.
    Dankerl A; Liebisch P; Glatting G; Friesen C; Blumstein NM; Kocot D; Wendl C; Bunjes D; Reske SN
    Radiology; 2007 Feb; 242(2):498-508. PubMed ID: 17179397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer.
    Nedrow JR; Latoche JD; Day KE; Modi J; Ganguly T; Zeng D; Kurland BF; Berkman CE; Anderson CJ
    Mol Imaging Biol; 2016 Jun; 18(3):402-10. PubMed ID: 26552656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrin alpha4beta1 involvement in stromal cell-derived factor-1alpha-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion.
    Parmo-Cabañas M; Bartolomé RA; Wright N; Hidalgo A; Drager AM; Teixidó J
    Exp Cell Res; 2004 Apr; 294(2):571-80. PubMed ID: 15023543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
    Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
    Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and Preclinical Evaluation of a
    Li H; Yuan L; Long Y; Fang H; Li M; Liu Q; Xia X; Qin C; Zhang Y; Lan X; Gai Y
    Mol Pharm; 2020 Aug; 17(8):3000-3008. PubMed ID: 32544337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploring pitfalls of
    Striese F; Sihver W; Gao F; Bergmann R; Walther M; Pietzsch J; Steinbach J; Pietzsch HJ
    Amino Acids; 2018 Oct; 50(10):1415-1431. PubMed ID: 30039310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. (64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.
    Kumar SR; Gallazzi FA; Quinn TP; Deutscher SL
    J Nucl Med; 2011 Nov; 52(11):1819-26. PubMed ID: 21984800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and comparative evaluation of novel (64)Cu-labeled high affinity cell-specific peptides for positron emission tomography imaging of tumor vasculature.
    Merrill JR; Krajewski K; Yuan H; Frank JE; Lalush DS; Patterson C; Veleva AN
    Biomaterials; 2016 Apr; 84():241-249. PubMed ID: 26839954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Copper 64-labeled daratumumab as a PET/CT imaging tracer for multiple myeloma.
    Caserta E; Chea J; Minnix M; Poku EK; Viola D; Vonderfecht S; Yazaki P; Crow D; Khalife J; Sanchez JF; Palmer JM; Hui S; Carlesso N; Keats J; Kim Y; Buettner R; Marcucci G; Rosen S; Shively J; Colcher D; Krishnan A; Pichiorri F
    Blood; 2018 Feb; 131(7):741-745. PubMed ID: 29301755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.